Merkel Cell Polyomavirus—Pathophysiology and Treatment in the Era of Gene‐Targeted Therapies
Open Access
- 3 September 2024
- journal article
- review article
- Published by Wiley in Reviews in Medical Virology
- Vol. 34 (5) , e2580
Abstract
Merkel cell polyomavirus (MCPyV) is a significant contributor to the development of Merkel cell carcinoma (MCC), an aggressive skin cancer with high recurrence and a low survival rate. In fact, it is the deadliest skin cancer. The precise routes of transmission for MCPyV‐positive MCC remain unclear, but several factors may trigger its development. Conventional treatments for MCC are not highly effective, especially in patients with metastasis, with a clear need for new treatment options. Gene‐targeted therapies hold great promise for the treatment of MCC, including the use of siRNA and CRISPR/Cas (C/Cas) but critically none have yet been translated into clinical trials. Validating this approach is the fact that several siRNA products are already FDA licenced, while C/Cas has entered clinical trial, albeit for conditions other than MCC. There are many challenges that must be overcome to move from preclinical research to the clinic. In this review, we provide a comprehensive summary of the current understanding of MCC, with a particular focus on MCPyV‐positive MCC, and the status of gene‐targeted therapies. Additionally, we discuss the major obstacles that impede MCC research and explore future prospects.Keywords
Funding Information
- Griffith University
- National Health and Medical Research Council (2027649, 2027569)
This publication has 41 references indexed in Scilit:
- Analysis of a hit‐and‐run tumor model by HPV in oropharyngeal cancersJournal of Medical Virology, 2022
- Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline – Update 2022European Journal of Cancer, 2022
- Merkel cell carcinoma: Epidemiology, disease presentation, and current clinical practice outcomesJAAD International, 2022
- Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From DiagnosisJAMA Dermatology, 2022
- International Increases in Merkel Cell Carcinoma Incidence Rates between 1997 and 2016Journal of Investigative Dermatology, 2021
- Merkel cell polyomavirus T-antigens regulate DICER1 mRNA stability and translation through HSC70iScience, 2021
- CRISPR/Cas Systems in Genome Editing: Methodologies and Tools for sgRNA Design, Off‐Target Evaluation, and Strategies to Mitigate Off‐Target EffectsAdvanced Science, 2020
- MCPyV Large T Antigen-Induced Atonal Homolog 1 Is a Lineage-Dependency Oncogene in Merkel Cell CarcinomaJournal of Investigative Dermatology, 2020
- Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus InfectionCell Host & Microbe, 2016
- Trabecular Carcinoma of the SkinArchives of Dermatology, 1972